Answers are grounded in this paper and cite their sources.
Interview with Dr. Stacie Dusetzina on three proposals for redesigning the Medicare Part D prescription-drug benefit. (09:54)Download Amid concerns about high drug prices, policymakers are considering options for modifying the Medicare Part D prescription-drug benefit to reduce spending by beneficiaries and taxpayers. The redesigns being considered shift spending and benefit phases in various ways.
No takes yet. Share an insight, caveat, or question.
Dusetzina et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: